Results 101 to 110 of about 3,485 (208)

Postmenopozal kadınlarda etidronate' in idrar kalsiyum / kreatinin oranına etkisi : prospektif, randomize, placebo kontrollü çalışma

, 1996
Bu tezin, veri tabanı üzerinden yayınlanma izni bulunmamaktadır. Yayınlanma izni olmayan tezlerin basılı kopyalarına Üniversite kütüphaneniz aracılığıyla (TÜBESS üzerinden) erişebilirsiniz.İnönü Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum A.B ...
Küçük, Şenol
core  

Effectiveness of treatments to prevent femoral periprosthetic bone loss following total hip arthroplasty: a network meta-analysis. [PDF]

Front Pharmacol
Zhao ZH, Ling T, Ye S, Luo W, Ma JX, Ma X.   +5 more
europepmc   +1 more source

Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study

, 1998
Objective-To study the effect of cyclic etidronate in secondary prevention of corticosteroid induced osteoporosis. Methods-A double blind, randomised placebo controlled study comparing cyclic etidronate and placebo during two years in 37 postmenopausal ...
STALMANS, Rita, GEUSENS, Piet, Joly, J, Dequeker, J, Boonen, S, VANHOOF, Johan, RAUS, Jef, Nijs, J   +7 more
core  

Establishment of a medial arterial calcification model in C57BL/6J mice via arterial intimal injury. [PDF]

Cardiovasc Diagn Ther
Hu C, Wang Y, Zhang H, He T, Zhao M, Zhang H, Zhang T, Chen G, Shao M.   +8 more
europepmc   +1 more source

A disproportionality analysis of cardiac arrhythmia associated with bisphosphonates based on the FAERS database. [PDF]

Sci Rep
Wang F, Xu G, Wang Q, Wu X.
europepmc   +1 more source

Atypical osteomalacia after 2 year etidronate intermittent cyclic administration in osteoporosis.

, 1995
International audienceA 68-year-old postmenopausal woman with osteoporosis received intermittent cyclic etidronate therapy (400 mg/day). No concomitant diseases were noted.
Thomas, T, Lafage, M, Alexandre, C
core  

Effect of continuous chelation irrigation on transforming growth factor-β1 release: An <i>in vitro</i> assay. [PDF]

J Conserv Dent Endod
Sridhar SV, Kumaravadivel K, Vishwanath S, Mathew S, Thangavel B, Thangaraj DN.   +5 more
europepmc   +1 more source

The Effect of Etidronate on Alveolar Bone Remodeling in Dog Mandible

, 2001
Indiana University-Purdue University Indianapolis (IUPUI)Etidronate belongs to a class of drugs called bisphosphonates, which are prescribed for the treatment of osteoporosis and other metabolic bone diseases. The main effect of these drugs is to inhibit
Handick, Kimberly E.
core  

The liver regulates ectopic calcification in Abcc6-deficient models of pseudoxanthoma elasticum. [PDF]

J Clin Invest
Wang Y, Sun B, Ma F, Tao B, Gu Y, Zhou Z, Kim J, Zhang L, Liu Z, Ten Hoeve J, Stiles L, Fernandez Del Rio L, Pan C, Shirihai O, Xu S, Graeber TG, Sallam T, Pellegrini M, Lusis AJ, Deb A.   +19 more
europepmc   +1 more source

The prevention of early postmenopausal bone loss by cyclical etidronate therapy:a 2-year, double-blind, placebo-controlled study

, 1997
To determine whether intermittent cyclical etidronate therapy can prevent early postmenopausal bone ...
Blake, G M, Herd, R J, Ryan, P J, Balena, R, Fogelman, I   +4 more
core